Molybdenum is an essential dietary mineral used in supplements to support normal body processes. Maintaining adequate intake is supported; extra supplementation remains unproven for longevity. Enriched lettuce offers a short-term blood-sugar signal, but no established effective longevity dose or durable benefit. Long-term safety remains uncertain; kidney function, copper status, and total intake matter. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Plasma/serum or urinary molybdenum | No established optimization target; baseline and laboratory interval | Document exposure |
| Serum creatinine and estimated glomerular filtration rate | No molybdenum-specific target; baseline and clinically appropriate kidney range | Assess clearance |
| Serum copper and ceruloplasmin | No molybdenum-specific optimal range; laboratory interval and baseline | Detect imbalance |
| Complete blood count | No molybdenum-specific target; baseline hemoglobin and white-cell counts | Assess suspected copper effects |
| Serum uric acid | No molybdenum optimization target; baseline and existing gout-treatment target | Assess gout context |
| Fasting glucose | No molybdenum-specific optimal range; baseline and established diabetes goals | Test metabolic claims |
Cadence: No trial validates a monitoring cadence. Proposed: 2–4 weeks, then every 3–6 months during experimental use; earlier for symptoms. Routine screening is not established for adequately nourished adults.